MedPath

LOFTRAN CAP 30MG

LOFTRAN CAP 30MG

Discontinued
DIN Number

01919520

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

smithkline beecham pharma division of smithkline beecham inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01919520
AIG Number0114430001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05BA10 KETAZOLAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

KETAZOLAMActive
Strength: 30 MG / CAP
Monograph: KETAZOLAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.